In addition to the direct anti-cancer activities, it was demonstrated that PDE5 inhibitors may act as potential cancer chemopreventive agents, due to their ability to suppress 1-methyl-1-nitrosourea (MNU)-induced mammary carcinogenesis [233]. The gene discussed is PDE5A; the disease is cancer.